298 related articles for article (PubMed ID: 34167874)
1. Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations.
Ohsawa R; Sano H; Ikeda M; Sano S
J Dermatol Sci; 2021 Aug; 103(2):124-127. PubMed ID: 34167874
[No Abstract] [Full Text] [Related]
2. Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 Vaccine.
Merrill ED; Kashem SW; Amerson EH; Pincus LB; Lang UE; Shinkai K; Chang AY
JAMA Dermatol; 2021 Sep; 157(9):1128-1130. PubMed ID: 34319363
[No Abstract] [Full Text] [Related]
3. Recurrent Skin Rash, Epigastralgia, and Arthralgia After SARS-CoV-2 mRNA Immunization and Breakthrough Infection.
Katsube K; Nagai T; Watanabe T
Gastroenterology; 2024 Jul; 167(2):e5-e8. PubMed ID: 38199589
[No Abstract] [Full Text] [Related]
4. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
[TBL] [Abstract][Full Text] [Related]
5. Enanthem in Patients With COVID-19 and Skin Rash.
Jimenez-Cauhe J; Ortega-Quijano D; de Perosanz-Lobo D; Burgos-Blasco P; Vañó-Galván S; Fernandez-Guarino M; Fernandez-Nieto D
JAMA Dermatol; 2020 Oct; 156(10):1134-1136. PubMed ID: 32667631
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.
Balogun M; Millette D; Yip V; Chan SA; Lee P; Gamal N; Hashim N; Phillips D; Walsh M; Trehan P; Hanna-Bashara L; Abdullah A; Wernham A; Tso S
Clin Exp Dermatol; 2022 Mar; 47(3):614-616. PubMed ID: 34748655
[No Abstract] [Full Text] [Related]
7. Ribonucleic acid COVID-19 vaccine-associated cutaneous adverse drug events: a case series of two patients.
Lam M; Egail M; Bedlow AJ; Tso S
Clin Exp Dermatol; 2021 Aug; 46(6):1131-1134. PubMed ID: 33835617
[No Abstract] [Full Text] [Related]
8. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
[No Abstract] [Full Text] [Related]
9. Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine.
Jedlowski PM; Jedlowski MF
Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560802
[No Abstract] [Full Text] [Related]
10. Histopathological and immunohistochemical features of drug-induced exanthems.
Lisi P; Pelliccia S; Bellini V
G Ital Dermatol Venereol; 2014 Apr; 149(2):237-41. PubMed ID: 24819645
[TBL] [Abstract][Full Text] [Related]
11. Lichenoid drug eruption induced by colchicine: case report.
An I; Demir V; Akdeniz S
Cutan Ocul Toxicol; 2017 Jun; 36(2):199-200. PubMed ID: 27345420
[TBL] [Abstract][Full Text] [Related]
12. A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.
Lavery MJ; Nawimana S; Parslew R; Stewart L
Clin Exp Dermatol; 2021 Oct; 46(7):1325-1327. PubMed ID: 33914926
[No Abstract] [Full Text] [Related]
13. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older.
Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS
JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853
[TBL] [Abstract][Full Text] [Related]
14. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
Johnston MS; Galan A; Watsky KL; Little AJ
JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
[TBL] [Abstract][Full Text] [Related]
15. An 82-year-old man with new skin lesions after COVID-19 vaccination.
Choi PJ; Fajt ML
Allergy Asthma Proc; 2024 Jan; 45(1):70-73. PubMed ID: 38151735
[No Abstract] [Full Text] [Related]
16. New onset and exacerbation of oral lichenoid mucositis following SARS-CoV-2 infection or vaccination.
Alabdulaaly L; Sroussi H; Epstein JB
Oral Dis; 2022 Nov; 28 Suppl 2():2563-2567. PubMed ID: 35595719
[No Abstract] [Full Text] [Related]
17. Widespread cutaneous small vessel vasculitis secondary to COVID-19 infection.
Tahir A; Sohail Z; Nasim B; Parmar NV
Int J Dermatol; 2020 Oct; 59(10):1278-1279. PubMed ID: 32880974
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
Front Immunol; 2021; 12():728021. PubMed ID: 34646267
[TBL] [Abstract][Full Text] [Related]
19. Reply to "A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination" by Manaa et al.
Camela E; Scalvenzi M; Megna M; Potestio L; Guerrasio G; Fornaro L; Fabbrocini G; Costa C
Dermatol Ther; 2022 Dec; 35(12):e15881. PubMed ID: 36181410
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
